In this episode of OSP’s Digital Health Transformers podcast, “AI and Patient Visibility for Early Risk Detection”, Claritas Rx’s VP of Product, Meghna Misra, sits down with host Marty Hendricks to explore how AI is fundamentally changing the way biopharma and specialty pharmacies support patients on complex therapies. For patients navigating rare diseases, oncology, and CAR-T treatments, the stakes couldn’t be higher — delays in access, coverage hurdles, or lapses in adherence can have serious consequences. The challenge has always been that the healthcare system is deeply fragmented, making it nearly impossible to get a clear, real-time view of where a patient stands in their journey. Claritas Rx is tackling that problem head-on.
Meghna shares how her team is using AI not as a buzzword, but as a precision tool — one that connects data across pharmacies, clinics, hubs, and access programs to surface risks before they escalate. She discusses how Claritas Rx has achieved measurable results, including a 20% increase in fill rates and over 17% improvement in refill rates, by deploying models that predict discontinuation risk, refill abandonment, and coverage barriers well in advance. Her core philosophy: AI should shift care teams from hindsight to foresight, and from dashboards full of data to knowing exactly what action to take next.
Whether you’re in biopharma, healthcare technology, or product leadership, this conversation is packed with practical insight. Meghna breaks down how to thoughtfully integrate AI into patient care — starting with the problem, not the technology — and why explainability and keeping humans in the loop are non-negotiable in high-stakes healthcare settings. It’s a grounded, refreshingly honest take on what AI can actually do for patients today, and where it’s headed next.
